VerAvanti is developing a new medical device called a Scanning Fiber Endoscope (SFE). The patented- SFE offers the potential for interventional cardiologists to reduce sightline gaps that are critical to proactively diagnosing and treating individuals at-risk for stroke and cardiovascular events. VerAvanti is using advanced science and patented technology to create solutions that may one day help physicians find answers to strokes and heart attacks that often strike without warning. Illuminating risks, starts with seeing what is currently hidden.